关注
Bon Ham Yip
Bon Ham Yip
在 stjude.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Recent advances in CRISPR/Cas9 delivery strategies
BH Yip
Biomolecules 10 (6), 839, 2020
2392020
Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells
H Dolatshad, A Pellagatti, M Fernandez-Mercado, BH Yip, L Malcovati, ...
Leukemia 29 (5), 1092-1103, 2015
2352015
Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes
H Dolatshad, A Pellagatti, FG Liberante, M Llorian, E Repapi, V Steeples, ...
Leukemia 30 (12), 2322-2331, 2016
1432016
The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes
BH Yip, V Steeples, E Repapi, RN Armstrong, M Llorian, S Roy, J Shaw, ...
The Journal of clinical investigation 127 (6), 2206-2221, 2017
1082017
Production of lentiviral vectors using suspension cells grown in serum-free media
M Bauler, JK Roberts, CC Wu, B Fan, F Ferrara, BH Yip, S Diao, YI Kim, ...
Molecular Therapy-Methods & Clinical Development 17, 58-68, 2020
952020
Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics
M Fernandez-Mercado, BH Yip, A Pellagatti, C Davies, MJ Larrayoz, ...
Public Library of Science 7 (8), e42334, 2012
782012
ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts
S Valletta, H Dolatshad, M Bartenstein, BH Yip, E Bello, S Gordon, Y Yu, ...
Oncotarget 6 (42), 44061, 2015
772015
DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3
RS Bhansali, M Rammohan, P Lee, AP Laurent, Q Wen, P Suraneni, ...
The Journal of Clinical Investigation 131 (1), 2021
662021
TP53 suppression promotes erythropoiesis in del (5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients
G Caceres, K McGraw, BH Yip, A Pellagatti, J Johnson, L Zhang, K Liu, ...
Proceedings of the National Academy of Sciences 110 (40), 16127-16132, 2013
632013
Activation of the mTOR pathway by the amino acid L-leucine in the 5q-syndrome and other ribosomopathies
J Boultwood, BH Yip, C Vuppusetty, A Pellagatti, JS Wainscoat
Advances in biological regulation 53 (1), 8-17, 2013
512013
The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes
J Boultwood, H Dolatshad, SS Varanasi, BH Yip, A Pellagatti
Advances in biological regulation 54, 153-161, 2014
442014
Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+ progenitor cells
C Davies, BH Yip, M Fernandez‐Mercado, PS Woll, X Agirre, F Prosper, ...
British journal of haematology 160 (6), 842-850, 2013
302013
Mixed lineage leukemia protein in normal and leukemic stem cells
BH Yip, CWE So
Experimental Biology and Medicine 238 (3), 315-323, 2013
282013
Application of genome editing technologies to the study and treatment of hematological disease
A Pellagatti, H Dolatshad, BH Yip, S Valletta, J Boultwood
Advances in biological regulation 60, 122-134, 2016
272016
Impact of splicing factor mutations on pre-mRNA splicing in the myelodysplastic syndromes
B Ham Yip, H Dolatshad, S Roy, A Pellagatti, J Boultwood
Current Pharmaceutical Design 22 (16), 2333-2344, 2016
222016
Effects of L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts
BH Yip, A Pellagatti, C Vuppusetty, A Giagounidis, U Germing, ...
Leukemia 26 (9), 2154-2158, 2012
222012
PRR14L mutations are associated with chromosome 22 acquired uniparental disomy, age-related clonal hematopoiesis and myeloid neoplasia
A Chase, A Pellagatti, S Singh, J Score, WJ Tapper, F Lin, Y Hoade, ...
Leukemia 33 (5), 1184-1194, 2019
122019
Activation of the mTOR signaling pathway by L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts
BH Yip, C Vuppusetty, M Attwood, A Giagounidis, U Germing, ...
Leukemia 27 (8), 1760-1763, 2013
112013
B cell class switch recombination is regulated by DYRK1A through MSH6 phosphorylation
L Stoler-Barak, E Harris, A Peres, H Hezroni, M Kuka, P Di Lucia, ...
Nature communications 14 (1), 1462, 2023
52023
L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del (5q) myelodysplastic syndrome patients
E Bello, J Kerry, S Singh, BH Yip, R Kušec, S Killick, S Raynaud, ...
haematologica 103 (11), e496, 2018
52018
系统目前无法执行此操作,请稍后再试。
文章 1–20